The prognosis of patients diagnosed with cancer after starting hemodialysis appears comparable to that of patients with cancer in the general population.

The selection and schedule of treatment should depend on patient preference and toxicity potential, according to Azka Ali, MD.

Patients are significantly more likely to experience treatment-related cardiac events with osimertinib than with other EGFR TKIs, data suggest.

For female patients aged at least 66 years, odds of prevalent CVD up with locally advanced and metastatic disease.

This suggested model can be used to track whether regimens are consistently and promptly added based on promising early phase data, regimens are removed due to failure in confirmatory trials, or the ...